Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients

Future Oncol. 2020 Jan;16(2):4337-4339. doi: 10.2217/fon-2019-0624. Epub 2019 Dec 3.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / genetics
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology
  • Continuity of Patient Care*
  • Disease Progression
  • Humans
  • Molecular Targeted Therapy / methods
  • Neoplasm Metastasis
  • Precision Medicine / methods*
  • Survival Rate
  • Treatment Outcome

Substances

  • Biomarkers, Tumor